The association of endothelial nitric oxide synthase (eNOS) G894T gene polymorphism with responsiveness to a selective α1-blocker in men with benign prostatic hyperplasia related lower urinary tract symptoms-Reference-Cited by-同舟云学术

The association of endothelial nitric oxide synthase (eNOS) G894T gene polymorphism with responsiveness to a selective α1-blocker in men with benign prostatic hyperplasia related lower urinary tract symptoms

Published:2016-03-31 Issue:2 Volume:118 Page:313-319
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Lee Yung-Chin¹²,Juan Yung-Shun¹²³,Liu Chia-Chu¹²⁴,Bao Bo-Ying⁵⁶⁷,Wang Chii-Jye¹²,Wu Wen-Jeng¹²,Huang Chun-Nung¹²,Huang Shu-Pin¹²⁸

Affiliation:

1. Department of Urology; Kaohsiung Medical University Hospital; Kaohsiung Taiwan

2. Department of Urology; Faculty of Medicine; Kaohsiung Medical University; Kaohsiung Taiwan

3. Department of Urology; Kaohsiung Municipal Hsiao-Kang Hospital; Kaohsiung Taiwan

4. Department of Health; Executive Yuan; Pingtung Hospital; Pingtung Taiwan

5. Department of Pharmacy; China Medical University; Taichung Taiwan

6. Sex Hormone Research Center; China Medical University Hospital; Taichung Taiwan

7. Department of Nursing; Asia University; Taichung Taiwan

8. Graduate Institute of Medicine; College of Medicine; Kaohsiung Medical University; Kaohsiung Taiwan

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.13468/fullpdf

Reference36 articles.

1. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction;Irwin;BJU Int,2011

2. Doxazosin for treating lower urinary tract symptoms compatible with benign prostatic obstruction: a systematic review of efficacy and adverse effects;MacDonald;BJU Int,2004

3. Lower urinary tract symptoms, obesity and the metabolic syndrome;Moul;Curr Opin Urol,2010

4. Comparative rapid onset of efficacy between doxazosin gastrointestinal therapeutic system and tamsulosin in patients with lower urinary tract symptoms from benign prostatic hyperplasia: a multicentre, prospective, randomised study;Chung;Int J Clin Pract,2011

5. Doxazosin. An update of its clinical pharmacology and therapeutic applications in hypertension and benign prostatic hyperplasia;Fulton;Drugs,1995

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RETRACTED ARTICLE: Inducible nitric oxide synthase promotes differentiation of satellite cells and prevents stress urinary incontinence via HGF-mediated p38/MAPK signaling;World Journal of Urology;2020-06-18

2. Responsiveness to medical benign prostatic hyperplasia therapy: is there a genetic factor?;BJU International;2016-07-15

3. The impact factor may be flawed but important;BJU International;2016-07-15